No abstract

A novel furanone-containing antibacterial resin composite has been prepared and evaluated. compressive strength (CS) and Streptococcus mutans viability were used to evaluate the mechanical strength and antibacterial activity of the composites. The modified resin composites showed a significant antibacterial activity without substantially decreasing the mechanical strengths. With 5-30 % addition of the furanone derivative, the composite kept its original CS unchanged but showed a significant antibacterial activity with a 16-68 % reduction in the S. mutans viability. Further, the antibacterial function of the new composite was not affected by human saliva. The aging study indicates that the composite may have a long-lasting antibacterial function. Within the limitations of this study, it appears that the experimental antibacterial resin composite may potentially be developed into a clinically attractive dental restorative due to its high mechanical strength and antibacterial function.

The novel quaternary ammonium bromide (QAB)-containing oligomers were synthesized and applied for developing an antibacterial resin composite. Compressive strength (CS) and S. mutans (an oral bacteria strain) viability were used to evaluate the mechanical strength and antibacterial activity of the formed composites. All the QAB-modified resin composites showed significant antibacterial activity and mechanical strength reduction. Increasing chain length and loading significantly enhanced the antibacterial activity but dramatically reduced the CS as well. The 30-day aging study showed that the incorporation of the QAB accelerated the degradation of the composite, suggesting that the QAB may not be well suitable for development of antibacterial dental resin composites or at least the QAB loading should be well controlled, unlike its use in dental glass-ionomer cements. The work in this study is beneficial and valuable to those who are interested in studying antibacterial dental resin composites

This study reports the synthesis and evaluation of a novel non-leachable poly(quaternary ammonium salt) (PQAS)-containing antibacterial glass-ionomer cement. Fuji II LC cement was used for comparison. Compressive strength (CS) and Streptococcus mutans viability were used to evaluate strength and antibacterial activity, respectively. All specimens were conditioned in distilled water at 37 degrees C before testing. After the addition of 1-30% PQAS, both cements showed a reduction in CS, of 25-95% for Fuji II LC and 13-78% for the experimental cement, and a reduction in S. mutans viability, of 40-79% for Fuji II LC and 40-91% for the experimental cement. The experimental cement showed less CS reduction and higher antibacterial activity compared with Fuji II LC. The result also indicates that the cements are permanently antibacterial, with no leaching of PQAS. It appears that the experimental cement is a clinically attractive dental restorative that can be potentially used for longlasting restorations as a result of its high mechanical strength and permanent antibacterial function.

A novel PQAS-containing antibacterial glass-ionomer cement has been developed. The functional QAS and their constructed PQAS were synthesized, characterized, and formulated into the light-cured cements. Compressive strength (CS) and bacterial (S. mutans and lactobacillus) viability were used to evaluate the mechanical strength and antibacterial activity of the cements. Flexural (FS) and diametral tensile strengths (DTS) were tested as well. Fuji II LC cement was used as control. The specimens were conditioned in distilled water at 37 C for 24 h prior to testing. All the PQAS-containing cements showed a significant antibacterial activity, accompanying with an initial CS reduction. The effects of chain length, loading, and grafting ratio of the QAS were significant. Increasing chain length, loading, grafting ratio significantly enhanced antibacterial activity but reduced the initial CS of the formed cements. The antibacterial effect of the substitute chain lengths from free QAS seem more significant in water than those from their polymers (PQAS) after integrating to the cement. The experimental cement showed less CS reduction and higher antibacterial activity than Fuji II LC. The long-term aging study indicates that the cement might have a long-lasting antibacterial function with no PQAS leaching. Within the limitations of this study, it appears that the experimental cement is a clinically attractive dental restorative that can be potentially used for long-lasting restorations due to its high mechanical strength and long-lasting antibacterial function.

The novel non-leachable poly (quaternary ammonium salt) (PQAS)-containing antibacterial glass- ionomer cement has been developed. Compressive strength (CS) and S. mutans viability were used as tools for strength and antibacterial activity evaluations, respectively. All the specimens were conditioned in distilled water at 37?C prior to testing. Commercial glass-ionomer cement Fuji II LC was used as control. With PQAS addition, the studied cements showed a reduction in CS with 25-95% for Fuji II LC and 13-78% for the experimental cement and a reduction in S. mutans viability with 40-79% for Fuji II LC and 40-91% for the experimental cement. The experimental cement showed less CS reduction and higher antibacterial activity as compared to Fuji II LC. The long-term aging study indicates that the cements are permanently antibacterial with no PQAS leaching. It appears that the experimental cement is a clinically attractive dental restorative that can be potentially used for long- lasting restorations due to its high mechanical strength and permanent antibacterial function

To evaluate the efficacy of nanosilver antibacterial gel in the nursing and treatment of cervical erosion. A total of 108 patients with cervical erosion were selected, and based on the degree of erosion, they were treated with nanosilver antibacterial gel for 2∼3 courses through external application. The total efficacy rate of nanosilver antibacterial gel in the treatment of cervical erosion was 97.2%, and the total cure rate was 84.3%. Further, the cure rate was 94.8% for mild erosion, 83.3% for moderate erosion, and 42.9% for severe erosion. Nanosilver antibacterial gel has different degrees of curative effects on cervical erosion, and the curative effect is more significant in mild and moderate erosion patients compared to that in severe erosion patients.